Global Postmenopausal Vaginal Atrophy Drugs Market 2016-2020

Outlook of the postmenopausal vaginal atrophy (PVA) market

Extensive research carried out by the analysts at Technavio has shown that the global postmenopausal vaginal atrophy (PVA) market will grow at an impressive CAGR of more than 7% over the forecast period.The presence of favorable healthcare reforms in the US is one of the key factors driving this market in the coming years. The Affordable Care Act has increased the number of insured women and has been a driving factor in the treatment-seeking behavior of people with this condition. Moreover, this law provides Americans with better health security by putting in place comprehensive health insurance reforms that not only have lower health care costs but also expands the coverage. Therefore, the introduction of beneficial healthcare plans in the US will prompt more women to with PVA to seek treatment, thereby aiding in the growth of this market over the forecast period.

In this industry research report, the analysts have estimated that the paradigm shift to non-estrogenic therapies is one of the critical trends driving this market’s growth. Non-estrogenic therapies in PVA treatment are a paradigm shift from systemic estrogen treatments such as creams, patches, and gels. Moreover, the launch of late-stage pipeline products expected to shift the attention from vaginal creams and OTC classes toward vaginal tablets and oral therapies. Therefore, the growing adoption of non-estrogenic therapies will propel the growth of this market segment during the forecast period.

Segmentation by drug class and analysis of the PVA market

• Topical estrogen
• Systemic estrogen

The topical estrogen segment dominated the market and accounted for almost 60% of the market share. Topical estrogen supplies include vaginal creams, vaginal tablet, and vaginal ring to drive this market segment’s growth in the coming years.

Geographical segmentation and analysis of the PVA market

• Americas
• APAC
• EMEA

During 2015, the Americas dominated the market and accounted for almost 86% of the market share in terms of revenue. The US was the largest revenue contributor in the region, capturing a significant portion of the global market. The new and improved healthcare system along with better economic conditions is expected to drive this market in this region. Also, the increasing awareness about the benefits of PVA products encourages people to opt for this treatment. Moreover, in developed countries such as the US, women can freely discuss their symptoms with the physician creates not only awareness but also aids in early diagnosis, thereby spurring this market’s growth by 2020.

Competitive landscape and key vendors

The global PVA market is highly competitive due to the presence of both local and international drug manufacturers. The market is open to new players and has a lot of opportunities for growth.  The competitive environment is expected to increase in due to the product extensions, new products, and new applications of the products and services provided. 

Key vendors in this market are –

• Pfizer
• Allergan
• Shionogi
• Novo Nordisk
• Teva Pharmaceuticals

Other prominent vendors analyzed in this market research report are Bayer, Bionovo, EndoCeutics, Foamix Pharmaceuticals, Ligand Pharmaceuticals, Pantarhei Bioscience, Pep-Tonic Medical. TherapeuticsMD, and Upsher-Smith Laboratories.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global PVA market?
• What are the key market trends impacting the growth of the global PVA market?
• What are the challenges to market growth?
• Who are the key vendors in the global PVA market?
• What are the market opportunities and threats faced by the vendors in the global PVA market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of global PVA market?

Technavio also offers customization on reports based on specific client requirement